Context Therapeutics Inc (CNTX)

Currency in USD
0.705
+0.006(+0.86%)
Real-time Data·
CNTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CNTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.7000.720
52 wk Range
0.4902.750
Key Statistics
Prev. Close
0.699
Open
0.705
Day's Range
0.7-0.72
52 wk Range
0.49-2.75
Volume
49.38K
Average Volume (3m)
230.74K
1-Year Change
-69.74%
Book Value / Share
1.01
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.400
Upside
+665.96%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Context Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Context Therapeutics Inc Company Profile

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

Compare CNTX to Peers and Sector

Metrics to compare
CNTX
Peers
Sector
Relationship
P/E Ratio
−2.3x−0.4x−0.5x
PEG Ratio
−0.030.020.00
Price/Book
0.7x2.6x2.6x
Price / LTM Sales
-1.5x3.3x
Upside (Analyst Target)
-206.1%43.5%
Fair Value Upside
Unlock28.8%6.9%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 5.400
(+665.96% Upside)

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
-0.09 / -0.0592
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CNTX Income Statement

People Also Watch

41.37
BMNR
+7.53%
5.19
REPL
-5.73%
17.82
SRPT
+9.59%
0.603
PMN
+2.27%

FAQ

What Stock Exchange Does Context Therapeutics Trade On?

Context Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Context Therapeutics?

The stock symbol for Context Therapeutics is "CNTX."

What Is the Context Therapeutics Market Cap?

As of today, Context Therapeutics market cap is 64.59M.

What Is Context Therapeutics's Earnings Per Share (TTM)?

The Context Therapeutics EPS (TTM) is -0.35.

When Is the Next Context Therapeutics Earnings Date?

Context Therapeutics will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is CNTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Context Therapeutics Stock Split?

Context Therapeutics has split 0 times.

How Many Employees Does Context Therapeutics Have?

Context Therapeutics has 12 employees.

What is the current trading status of Context Therapeutics (CNTX)?

As of 07 Aug 2025, Context Therapeutics (CNTX) is trading at a price of 0.71, with a previous close of 0.70. The stock has fluctuated within a day range of 0.70 to 0.72, while its 52-week range spans from 0.49 to 2.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.